Bharat Biotech’s Intranasal Vaccine Gets Nod For Phase II Trials
New Delhi: Bharat Biotech's intranasal vaccine is the first nasal vaccine that has received the regulatory approval for Phase 2 trials. This is the first of its kind COVID-19 jab to undergo human clinical trials in India. BBV154 is an…